203 related articles for article (PubMed ID: 20950952)
21. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of patients with head-and-neck cancer of unknown primary origin treated with intensity-modulated radiotherapy.
Shoushtari A; Saylor D; Kerr KL; Sheng K; Thomas C; Jameson M; Reibel J; Shonka D; Levine P; Read P
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e83-91. PubMed ID: 21377283
[TBL] [Abstract][Full Text] [Related]
23. Merkel cell carcinoma of the head and neck: is adjuvant radiotherapy necessary?
Clark JR; Veness MJ; Gilbert R; O'Brien CJ; Gullane PJ
Head Neck; 2007 Mar; 29(3):249-57. PubMed ID: 17163472
[TBL] [Abstract][Full Text] [Related]
24. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
[TBL] [Abstract][Full Text] [Related]
25. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
26. Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community.
Maguire PD; Meyerson MB; Neal CR; Hamann MS; Bost AL; Anagnost JW; Ungaro PC; Pollock HD; McMurray JE; Wilson EP; Kotwall CA
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):698-704. PubMed ID: 14967423
[TBL] [Abstract][Full Text] [Related]
27. Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study.
Mohanti BK; Umapathy H; Bahadur S; Thakar A; Pathy S
Radiother Oncol; 2004 Jun; 71(3):275-80. PubMed ID: 15172142
[TBL] [Abstract][Full Text] [Related]
28. Salvage re-irradiation for recurrent head and neck cancer.
Lee N; Chan K; Bekelman JE; Zhung J; Mechalakos J; Narayana A; Wolden S; Venkatraman ES; Pfister D; Kraus D; Shah J; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):731-40. PubMed ID: 17379449
[TBL] [Abstract][Full Text] [Related]
29. Esophageal stricture after radiotherapy in patients with head and neck cancer: experience of a single institution over 2 treatment periods.
Ahlberg A; al-Abany M; Alevronta E; Friesland S; Hellborg H; Mavroidis P; Lind BK; Laurell G
Head Neck; 2010 Apr; 32(4):452-61. PubMed ID: 19672963
[TBL] [Abstract][Full Text] [Related]
30. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
[TBL] [Abstract][Full Text] [Related]
31. Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial".
Porceddu SV; Rosser B; Burmeister BH; Jones M; Hickey B; Baumann K; Gogna K; Pullar A; Poulsen M; Holt T
Radiother Oncol; 2007 Dec; 85(3):456-62. PubMed ID: 18036689
[TBL] [Abstract][Full Text] [Related]
32. Results of treatment intensification for progressive locoregional disease in head-and-neck cancer patients undergoing postoperative radiotherapy.
Corry J; Rischin D; Mukesh BN; Porceddu S; Peters LJ
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1416-22. PubMed ID: 15817345
[TBL] [Abstract][Full Text] [Related]
33. Improved survival in patients with Stage III-IV Head and neck cancer treated with radiotherapy as primary local treatment modality.
Rusthoven KE; Raben D; Chen C
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):343-50. PubMed ID: 18374508
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in oropharyngeal cancer--analysis of 627 cases receiving definitive radiotherapy.
Agarwal JP; Mallick I; Bhutani R; Ghosh-Laskar S; Gupta T; Budrukkar A; Murthy V; Sengar M; Dinshaw KA
Acta Oncol; 2009; 48(7):1026-33. PubMed ID: 19363712
[TBL] [Abstract][Full Text] [Related]
35. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Salama JK; Stenson KM; List MA; Mell LK; Maccracken E; Cohen EE; Blair E; Vokes EE; Haraf DJ
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1060-5. PubMed ID: 18936351
[TBL] [Abstract][Full Text] [Related]
36. Extranodal nonorbital indolent lymphomas of the head and neck: relationship between tumor control and radiotherapy.
MacDermed D; Thurber L; George TI; Hoppe RT; Le QT
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):788-95. PubMed ID: 15183482
[TBL] [Abstract][Full Text] [Related]
37. Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy.
Meyer F; Fortin A; Wang CS; Liu G; Bairati I
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1454-62. PubMed ID: 21640495
[TBL] [Abstract][Full Text] [Related]
38. Impact of pretreatment body mass index on patients with head-and-neck cancer treated with radiation.
Pai PC; Chuang CC; Tseng CK; Tsang NM; Chang KP; Yen TC; Liao CT; Hong JH; Chang JT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e93-e100. PubMed ID: 22342298
[TBL] [Abstract][Full Text] [Related]
39. How intensive should radiotherapy for head and neck cancer with synchronous distant metastases be? Review of cases.
Ampil FL; Kim DD; Ghali GE; Baluna RG
J Oral Maxillofac Surg; 2012 Mar; 70(3):730-3. PubMed ID: 21783296
[TBL] [Abstract][Full Text] [Related]
40. Risk of xerostomia in association with the receipt of radiation therapy in older patients with head and neck cancer.
Liu CC; Xia R; Guadagnolo A; Cormier JN; Du XL
Am J Ther; 2011 May; 18(3):206-15. PubMed ID: 20068441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]